cro.directory
← Compare landing

Cellentia, Inc. vs TRiCBIO

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellentiabio/tricbio

CategoryCellentia, Inc.TRiCBIO
Listed sitecrocro
SummaryCellentia is a specialized contract research organization offering custom bioassay development, patient-derived 3D tumor organoid models, AAV and MSD assays, PBMC isolation, and mycoplasma detection services to support drug discovery and translational research.TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
Services
  • Translational Research
  • Biomarker Assays
  • In Vitro Pharmacology
  • Translational Research
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Target Identification & Validation
  • Discovery Research
  • Medicinal Chemistry
  • Biomarker Assays
  • Flow Cytometry Services
Modalities
  • AAV / Viral Vector Platform
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Oncology
  • Oncology
  • Immunology
  • Rare Disease
  • Gastroenterology
Locations
  • Headquarters, Mountain View, California, United States
  • Nanjing, Nanjing, China
  • Shanghai, Shanghai, China
  • Philadelphia, Philadelphia, Pennsylvania, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.